Literature DB >> 20432251

Clearing the smoke in chronic liver diseases.

Claudia O Zein.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20432251      PMCID: PMC3587141          DOI: 10.1002/hep.23694

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  35 in total

1.  Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

2.  Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

Authors:  F Pessione; M J Ramond; C Njapoum; V Duchatelle; C Degott; S Erlinger; B Rueff; D C Valla; F Degos
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study.

Authors:  J C Will; D A Galuska; E S Ford; A Mokdad; E E Calle
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

4.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.

Authors:  Shannon M Bailey; Sudheer K Mantena; Telisha Millender-Swain; Yavuz Cakir; Nirag C Jhala; David Chhieng; Kent E Pinkerton; Scott W Ballinger
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

6.  The health risks of smoking. The Framingham Study: 34 years of follow-up.

Authors:  K M Freund; A J Belanger; R B D'Agostino; W B Kannel
Journal:  Ann Epidemiol       Date:  1993-07       Impact factor: 3.797

7.  Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice.

Authors:  Jeon-Ok Moon; Timothy P Welch; Frank J Gonzalez; Bryan L Copple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-08       Impact factor: 4.052

8.  Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice.

Authors:  Hui Chen; Michelle J Hansen; Jessica E Jones; Ross Vlahos; Gary P Anderson; Margaret J Morris
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-16       Impact factor: 4.310

9.  Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

Authors:  Vladimir Savransky; Shannon Bevans; Ashika Nanayakkara; Jianguo Li; Philip L Smith; Michael S Torbenson; Vsevolod Y Polotsky
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-08-09       Impact factor: 4.052

10.  Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1.

Authors:  Hongwei Yuan; John Y-J Shyy; Manuela Martins-Green
Journal:  J Hepatol       Date:  2009-05-18       Impact factor: 25.083

View more
  8 in total

1.  Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.

Authors:  Anna S Lok; James E Everhart; Elizabeth C Wright; Adrian M Di Bisceglie; Hae-Young Kim; Richard K Sterling; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Timothy R Morgan
Journal:  Gastroenterology       Date:  2010-12-01       Impact factor: 22.682

2.  Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.

Authors:  Ayaka Hamabe; Hirofumi Uto; Yasushi Imamura; Ken Kusano; Seiichi Mawatari; Kotaro Kumagai; Takeshi Kure; Tsutomu Tamai; Akihiro Moriuchi; Toshio Sakiyama; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2011-02-08       Impact factor: 7.527

3.  Enzymatic Responses to Alcohol and Tobacco Nicotine-Derived Nitrosamine Ketone Exposures in Long Evans Rat Livers.

Authors:  E B Yalcin; M Tong; S M de la Monte
Journal:  Austin Liver       Date:  2016-12-01

4.  A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.

Authors:  Bhavin Parekh
Journal:  F1000Res       Date:  2015-05-14

5.  Tobacco Smoke and CYP1A2 Activity in a US Population with Normal Liver Enzyme Levels.

Authors:  Alexis Garduno; Tianying Wu
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390

Review 6.  Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease.

Authors:  Fu-Shun Yen; Chih-Cheng Hsu; James Cheng-Chung Wei; Ming-Chih Hou; Chii-Min Hwu
Journal:  Front Med (Lausanne)       Date:  2022-02-16

Review 7.  Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis.

Authors:  Michael Roerecke; Radu Nanau; Jürgen Rehm; Manuela Neuman
Journal:  EBioMedicine       Date:  2016-04-20       Impact factor: 8.143

8.  Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.

Authors:  Peiyi Liu; Yanyan Xu; Yuhan Tang; Min Du; Xiao Yu; Jian Sun; Lin Xiao; Meian He; Sheng Wei; Jing Yuan; Youjie Wang; Yuan Liang; Tangchun Wu; Xiaoping Miao; Ping Yao
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.